Advarra is a leading provider of integrated clinical research solutions, specializing in Institutional Review Board (IRB) services, clinical trial technology, and consulting for the life sciences industry. Founded in 2017 through the merger of Chesapeake IRB and CIRBI, Advarra has grown to become one of the most trusted names in research compliance and ethics review. The company’s mission is to advance clinical research by improving efficiency, enhancing participant safety, and ensuring regulatory compliance across the globe.
With a workforce exceeding 1,000 employees, Advarra serves pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and academic institutions. Its offerings include research compliance oversight, site optimization, and advanced technology platforms such as Advarra EDC and Advarra eConsent. The company is recognized for its strong market position in the IRB sector and has recently expanded its capabilities through strategic acquisitions, reinforcing its role as a comprehensive partner for clinical research stakeholders.